Of particular interest is our observation that CD8+ T cells derived from GBM central regions, characterised by elevated NUCB2 expression, exhibit unique transcriptional profiles enriched for interferon signalling, complement activation and inflammatory pathways. This evidence concerns the gene CD8A and glioblastoma.